Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: A population-based linkage study

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Gidding, Heather F ^a   Dore, Gregory J ^a   Amin, Janaki ^a   Law, Matthew G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; ISOLATION AND PURIFICATION; LIVER DISEASE; MALE; MEDICAL RECORD; METHODOLOGY; MORTALITY; POISSON DISTRIBUTION; VIROLOGY;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HOSPITALIZATION; HUMANS; LIVER DISEASES; MALE; MEDICAL RECORD LINKAGE; NEW SOUTH WALES; POISSON DISTRIBUTION; POPULATION SURVEILLANCE;

EID: 78751646121     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-52     Document Type: Article

References (51)

1. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG: Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006, 45(2):197-203.
2. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ: Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006, 368(9539):938-945. (Pubitemid 44331386)
3. Duberg A-S, Torner A, Davidsdottir L, Aleman S, Blaxhult A, Svensson A, Hultcrantz R, Back E, Ekdahl K: Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat 2008, 15(7):538-550. (Pubitemid 351798992)
4. McDonald SA, Hutchinson SJ, Bird SM, Mills PR, Dillon J, Bloor M, Robertson C, Donaghy M, Hayes P, Graham L, Goldberg DJ: A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Stat Methods Med Res 2009, 18(3):271-283.
5. McDonald SA, Hutchinson SJ, Bird SM, Robertson C, Mills PR, Dillon JF, Goldberg DJ: A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland. Br J Cancer 2008, 99(5):805-810.
6. Omland LH, Jepsen P, Skinhoj P, Jorgensen HL, Munster AMB, Bangsborg J, Fenger M, Sorensen HT, Obel N: The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study. HIV Medicine 2009, 10(2):65-71.
7. Steinke DT, Weston TL, Morris AD, MacDonald TM, Dillon JF: Epidemiology and economic burden of viral hepatitis: an observational population based study. Gut 2002, 50(1):100-105. (Pubitemid 34028311)
8. Chang T-T, Lai C-L, Kew Yoon S, Lee SS, Coelho HSM, Carrilho FJ, Poordad F, Halota W, Horsmans Y, Tsai N, Zhang H, Tenney DJ, Tamez R, Iloeje U: Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology 2010, 51(2):422-430.
9. Liaw Y-F, Gane E, Leung N, Zeuzem S, Wang Y, Lai CL, Heathcote EJ, Manns M, Bzowej N, Niu J, Han S-H, Hwang SG, Cakaloglu Y, Tong MJ, Papatheodoridis G, Chen Y, Brown NA, Albanis E, Galil K, Naoumov NV, The Globe Study Group: 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology 2009, 136(2):486-495.
10. Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F: Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008, 359(23):2442-2455.
11. Chang T-T, Liaw Y-F, Wu S-S, Schiff E, Han K-H, Lai C-L, Safadi R, Lee SS, Halota W, Goodman Z, Chi Y-C, Zhang H, Hindes R, Iloeje U, Beebe S, Kreter B: Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 2010, 52(3):886-893.
12. Liaw Y-F, Sung JJY, Chow WC, Farrell G, Lee C-Z, Yuen H, Tanwandee T, Tao Q-M, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J, Cirrhosis Asian Lamivudine Multicentre Study Group: Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004, 351(15):1521-1531.
13. Matthews GV, Cooper DA, Dore GJ: Improvements in parameters of endstage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir. Antiviral Therapy 2007, 12(1):119-122. (Pubitemid 46340434)
14. Schiff ER, Lai C-L, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann HL, Samuel D, Zeuzem S, Lilly L, Rendina M, Villeneuve J-P, Lama N, James C, Wulfsohn MS, Namini H, Westland C, Xiong S, Choy GS, Van Doren S, Fry J, Brosgart CL, The Adefovir Dipovoxil Study 435 International Investigators Group: Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology 2003, 38(6):1419-1427. (Pubitemid 37466968)
15. Population Health Division: The health of the people of New South Wales - Report of the Chief Health Officer. Sydney: NSW Department of Health; 2009.
16. McDonald AM, Crofts N, Kaldor JM, National HIV Surveillance Committee: A national surveillance system for newly acquired HIV infection in Australia. Am J Public Health 1994, 84(12):1923-1928.
17. Kaldor J, McDonald AM, Blumer CE, Gertig DM, Patten JJ, Roberts M, Walker CC, Mullins SE, Bailey KA, Chuah JCP: The acquired immunodeficiency syndrome in Australia: incidence 1982 - 1991. Med J Aust 1993, 158:10-17.
18. The Centre for Health Record Linkage. [http://www.cherel.org.au].
19. ChoiceMaker Technologies Inc: New York, NY10010 .
20. Stukel TA, Glynn RJ, Fisher ES, Sharp SM, Lu-Yao G, Wennberg JE: Standardized rates of recurrent outcomes. Stat Med 1994, 13(17):1781-1791. (Pubitemid 24284860)
21. Kirkwood BR, Sterne JAC: Essential medical statistics. Malden, Massachusetts: Blackwell Science Ltd;, 2 2003.
22. Razali K, Thein H, Bell J, Cooper-Stanbury M, Dolan K, Dore GJ, George J, Kaldor JM, Karvelas M, Li J, Maher L, McGregor S, Hellard M, Poeder F, Quaine J, Stewart K, Tyrrell H, Weltman M, Westcott O, Wodak A, Law M: Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend 2007, 91(2-3):228-235. (Pubitemid 47539727)
23. O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ: Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust NZ J Public Health 2004, 28(3):212-216.
24. Gidding HF, Amin J, Dore GJ, Ward K, Law MG: Hospital-related morbidity in people notified with hepatitis C; a population-based record linkage study in New South Wales, Australia. J Hepatol 2010, 53:43-49.
25. Singh GK, Siahpush M: Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: an analysis of two national data bases. Hum Biol 2002, 74(1):83-109. (Pubitemid 34220324)
26. Thein H-H, Yi Q, Dore GJ, Krahn MD: Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 2008, 48(2):418-431.
27. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J: Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001, 34(5):730-739. (Pubitemid 32488789)
28. Iloeje UH, Yang H-I, Su J, Jen C-L, You S-L, Chen C-J, Risk Evaluation of Viral Load E, Associated Liver Disease/Cancer-In HBVSG: Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006, 130(3):678-686.
29. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T, The Multivirc Group: Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 1999, 30(4):1054-1058. (Pubitemid 29458296)
30. Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, De Moerloose P, White GC, Angiolillo AL, Luban NLC, Sherman KE, Manco-Johnson M, Preiss L, Leissinger C, Kessler CM, Cohen AR, DiMichele D, Hilgartner MW, Aledort LM, Kroner BL, Rosenberg PS, Hatzakis A: End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002, 100(5):1584-1589. (Pubitemid 34925132)
31. Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, Piccinino F: Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000, 32(5):1106-1110.
32. Thein H-H, Yi Q, Dore GJ, Krahn MD: Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008, 22(15):1979-1991.
33. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, Tran van Nhieu J, Seigneurin JM, Buffet C, Dhumeaux D: Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998, 28(1):27-33. (Pubitemid 28122496)
34. Bodsworth N, Donovan B, Nightingale BN: The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis 1989, 160(4):577-582.
35. Puoti M, Torti C, Bruno R, Filice G, Carosi G: Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006, 44(1 Suppl):S65-70.
36. Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, Precone D, Gelatti U, Asensi V, Vaccher E, Group HHCI-S: Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004, 18(17):2285-2293. (Pubitemid 39620221)
37. Gidding HF, Topp L, Middleton M, Robinson K, Hellard M, McCaughan G, Maher L, Kaldor JM, Dore GJ, Law MG: The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997-2006. J Gast Hepatol 2009, 24(10):1648-1654.
38. National Centre in HIV Epidemiology and Clinical Research: HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2009 University of NSW, Sydney; 2009.
39. Cheng WSC, Roberts S, Weltman M, Crawford DHG, Sievert W, McCaughan G, Rawlinson W, Desmond P, Yoshihara M, Rizkalla B, DePamphilis J, Marks P, Dore GJ: Efficacy and safety of Peginterferon alfa-2A 360 μg/week in combination with ribavirin in hepatitis C genotype 1 patients with cirrhosis: analysis from the CHARIOT study. J Hepatol 2009, 50:S221.
40. Dore GJ, Cooper DA, Pozniak AL, DeJesus E, Zhong L, Miller MD, Lu B, Cheng AK, Study T, Study T: Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus. J Infect Dis 2004, 189(7):1185-1192. (Pubitemid 38457242)
41. Kim WR, Terrault NA, Pedersen RA, Therneau TM, Edwards E, Hindman AA, Brosgart CL: Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology 2009, 137(5):1680-1686.
42. Walter SR, Thein H-H, Amin J, Gidding HF, Ward K, Law MG, George J, Dore GJ: Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006. J Hepatol 2010.
43. Amin J, O'Connell D, Bartlett M, Tracey E, Kaldor J, Law M, Dore G: Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study. Aust NZ J Public Health 2007, 31(5):475-482.
44. Alam N, Chen W, Baker D, Bishop J: Liver Cancer in New South Wales Sydney Cancer Institute NSW; 2009.
45. Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ: Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology 2005, 129(2):486-493. (Pubitemid 41096636)
46. Fattovich G, Stroffolini T, Zagni I, Donato F: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004, 127(5 Suppl 1): S35-50.
47. Blum HE, Moradpour D: Viral pathogenesis of hepatocellular carcinoma. J Gastroenterol Hepatol 2002, 17(Suppl 3):S413-420.
48. Grant WC, Jhaveri RR, McHutchison JG, Schulman KA, Kauf TL: Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology 2005, 42(6):1406-1413. (Pubitemid 43260044)
49. Myers RP, Liu M, Shaheen AA: The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004. Can J Gastroenterol 2008, 22(4):381-387.
50. Thomson SJ, Westlake S, Rahman TM, Cowan ML, Majeed A, Maxwell JD, Kang J-Y: Chronic liver disease-an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcoholic liver disease. Alcohol Alcohol 2008, 43(4):416-422.
51. Micallef JM, Kaldor JM, Dore GJ: Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006, 13(1):34-41.